RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5 | +25.0% | 227 | 0.0% | 0.00% | – |
Q2 2023 | $4 | 0.0% | 227 | 0.0% | 0.00% | – |
Q1 2023 | $4 | -42.9% | 227 | 0.0% | 0.00% | – |
Q4 2022 | $7 | -99.8% | 227 | +32.0% | 0.00% | – |
Q3 2022 | $4,000 | +300.0% | 172 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 172 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 172 | +75.5% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 98 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 98 | +18.1% | 0.00% | – |
Q4 2020 | $2,000 | -60.0% | 83 | -66.5% | 0.00% | – |
Q3 2020 | $5,000 | +25.0% | 248 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 248 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -33.3% | 248 | 0.0% | 0.00% | – |
Q4 2019 | $6,000 | +20.0% | 248 | +13.2% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 219 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -16.7% | 219 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | -25.0% | 219 | -27.0% | 0.00% | – |
Q4 2018 | $8,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |